{'fraction_non_alphanumeric': 0.03208556149732621, 'fraction_numerical': 0.01871657754010695, 'mean_word_length': 5.747747747747748, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
[Treatment of functional sterility using a clomiphene-Sterolibrin combination].

Out of 252 women with primary or secondary sterility, 107 women with functional sterility with anovulation cycles were selected for hormonal therapy. These women received Clomifen citrate after menstruation, and a push dose of an oestroprogestative combination, Sterolibirin, before menstruation. After this therapy, in 71 women (66%) ovulation cycles were produced; of this number, 49 women (46%) became pregnant to date. No statistically significant correlations could be revealed with respect to the ages of the women treated, duration of sterility, duration of medication, nor between the respective results achieved in women with primary and secondary sterility.